{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:09:29Z","timestamp":1767852569657,"version":"3.49.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.beha.2009.01.003","type":"journal-article","created":{"date-parts":[[2009,3,12]],"date-time":"2009-03-12T08:23:52Z","timestamp":1236846232000},"page":"103-114","source":"Crossref","is-referenced-by-count":76,"title":["Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment"],"prefix":"10.1016","volume":"22","author":[{"given":"Ulrike","family":"Nowak-G\u00f6ttl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gili","family":"Kenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley G.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2009.01.003_bib1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","article-title":"Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE","volume":"83","author":"Andrew","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.beha.2009.01.003_bib2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1067\/mpd.2001.118192","article-title":"Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands","volume":"139","author":"Van Ommen","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.beha.2009.01.003_bib3","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040161","article-title":"Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children","volume":"351","author":"Goldenberg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2009.01.003_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.thromres.2003.09.008","article-title":"A cross-sectional study evaluating post-thrombotic syndrome in children","volume":"111","author":"Kuhle","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2009.01.003_bib5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1203\/00006450-200006000-00013","article-title":"Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry","volume":"47","author":"Monagle","year":"2000","journal-title":"Pediatr Res"},{"key":"10.1016\/j.beha.2009.01.003_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1160\/TH04-04-0207","article-title":"Systemic thromboembolism in children. Data from the 1-800-NO-CLOTS Consultation Service","volume":"92","author":"Kuhle","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2009.01.003_bib7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/pbc.21734","article-title":"Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer","volume":"51","author":"Athale","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.beha.2009.01.003_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.mop.0000193270.09001.ea","article-title":"Thrombosis in children with malignancy","volume":"18","author":"Bajzar","year":"2006","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.beha.2009.01.003_bib9","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1182\/blood-2006-04-015511","article-title":"Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients","volume":"108","author":"Caruso","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2009.01.003_bib10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2141.2007.06677.x","article-title":"Thrombosis and acute lymphoblastic leukaemia","volume":"138","author":"Payne","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2009.01.003_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.mbc.0000214709.11492.ec","article-title":"Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases","volume":"17","author":"Appel","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.beha.2009.01.003_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0609.1995.tb00699.x","article-title":"Effects of Erwinia-asparaginase on the coagulation system","volume":"55","author":"Carlsson","year":"1995","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.beha.2009.01.003_bib13","first-page":"567","article-title":"Thrombotic complications during L-asparaginase treatment for acute lymphocytic leukemia","volume":"75","author":"Castaman","year":"1990","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2009.01.003_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-2008-1046624","volume":"206","author":"Eckhof-Donovan","year":"1994","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.beha.2009.01.003_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/mpo.2950180612","article-title":"Non-randomised study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukaemia","volume":"18","author":"Eden","year":"1990","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.beha.2009.01.003_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.leu.2404560","article-title":"Risk factors of central venous lines-related thrombosis in children with acute lymphoblastic leukemia during induction therapy: a prospective study","volume":"21","author":"Farinasso","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2009.01.003_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1442-200X.2002.01556.x","article-title":"Low plasma levels of hemostatic proteins during the induction phase in children with acute lymphoblastic leukemia: a retrospective study by the JACLS. Japan Association of Childhood Leukemia Study","volume":"44","author":"Hongo","year":"2002","journal-title":"Pediatr Int"},{"key":"10.1016\/j.beha.2009.01.003_bib18","article-title":"The complex nature of the prothrombotic state in acute lymphoblastic leukemia of childhood","volume":"88","author":"Jaime-Perez","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2009.01.003_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-2008-1043893","article-title":"Coagulation and fibrinolysis in children with acute lymphoblastic leukaemia treated according to the COALL-05-92-protocol","volume":"210","author":"Kirschke","year":"1998","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.beha.2009.01.003_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-2008-1046625","article-title":"Increased thrombin generation during fibrinogen and platelet recovery as an explanation for hypercoagulability in children with L-asparaginase therapy for ALL or NHL: a preliminary report","volume":"206","author":"Korte","year":"1994","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.beha.2009.01.003_bib21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/1097-0142(19850215)55:4<702::AID-CNCR2820550405>3.0.CO;2-N","article-title":"Thromboembolic complications associated with L-asparaginase therapy. Etiologic role of low antithrombin III and plasminogen levels and therapeutic correction by fresh frozen plasma","volume":"55","author":"Kucuk","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2009.01.003_bib22","first-page":"179","article-title":"Intravascular coagulation phenomena associated with prevalent fall in fibrinogen and plasminogen during L-asparaginase treatment in leukemic children","volume":"18","author":"Legnani","year":"1988","journal-title":"Haemostasis"},{"key":"10.1016\/j.beha.2009.01.003_bib23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1055\/s-0037-1613930","article-title":"Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols)","volume":"83","author":"Mauz-K\u00f6rholz","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2009.01.003_bib24","first-page":"116","article-title":"Hemostatic changes in children with acute lymphoblastic leukemia treated according to two different L-asparaginase schedules","volume":"8","author":"Miniero","year":"1986","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.beha.2009.01.003_bib25","first-page":"120","article-title":"Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia","volume":"16","author":"Mitchell","year":"1994","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.beha.2009.01.003_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/cncr.11042","volume":"97","author":"Mitchell","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2009.01.003_bib27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2008-1046646","article-title":"Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and alpha 2-antiplasmin in children using the new Automated Coagulation Laboratory (ACL) method","volume":"206","author":"Nowak-G\u00f6ttl","year":"1994","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.beha.2009.01.003_bib28","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/0268-9499(94)90249-6","article-title":"Influence of two different asparaginase preparations on coagulation and fibrinolysis: a randomised trial","volume":"8","author":"Nowak-G\u00f6ttl","year":"1994","journal-title":"Fibrinolysis"},{"key":"10.1016\/j.beha.2009.01.003_bib29","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/00001721-199610000-00004","article-title":"Ischaemic stroke in infancy and childhood: role of the Arg506 to Gln mutation in the factor V gene","volume":"7","author":"Nowak-G\u00f6ttl","year":"1996","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.beha.2009.01.003_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2141.1996.d01-1873.x","article-title":"Changes in coagulation and fibrinolysis in childhood ALL: a two-step dose reduction of one E. coli asparaginase preparation","volume":"95","author":"Nowak-G\u00f6ttl","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2009.01.003_bib31","first-page":"127","article-title":"Influence of two different Escherichia coli asparaginase preparations on fibrinolytic proteins in childhood ALL","volume":"81","author":"Nowak-G\u00f6ttl","year":"1996","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2009.01.003_bib32","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s004310050727","article-title":"Changes in coagulation and fibrinolysis in childhood acute lymphoblastic leukaemia re-induction therapy using three different asparaginase preparations","volume":"156","author":"Nowak-G\u00f6ttl","year":"1997","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.beha.2009.01.003_bib33","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1182\/blood.V94.11.3678","article-title":"Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood","volume":"94","author":"Nowak-G\u00f6ttl","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2009.01.003_bib34","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood.V93.5.1595","article-title":"Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors","volume":"93","author":"Nowak-G\u00f6ttl","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2009.01.003_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0049-3848(01)00281-X","article-title":"Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease. a prospective study","volume":"103","author":"Nowak-G\u00f6ttl","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2009.01.003_bib36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0022-3476(83)80212-1","article-title":"Thrombosis and hemorrhage during L-asparaginase therapy","volume":"102","author":"Pastore","year":"1983","journal-title":"J Pediatr"},{"key":"10.1016\/j.beha.2009.01.003_bib37","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/1097-0142(19801001)46:7<1548::AID-CNCR2820460709>3.0.CO;2-7","article-title":"Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia","volume":"46","author":"Priest","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2009.01.003_bib38","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0022-3476(82)80536-2","article-title":"The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia","volume":"100","author":"Priest","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.beha.2009.01.003_bib39","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0022-3476(82)80535-0","article-title":"A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia","volume":"100","author":"Priest","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.beha.2009.01.003_bib40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajh.2830250309","article-title":"Involvement of von Willebrand factor in thrombosis following asparaginase-prednisone-vincristine therapy for leukemia","volume":"25","author":"Pui","year":"1987","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2009.01.003_bib41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/mpo.2950230404","article-title":"Minimal effects of E. coli and Erwinia asparaginase on the coagulation system in childhood acute lymphoblastic leukemia: a randomized study","volume":"23","author":"Risseeuw-Appel","year":"1994","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.beha.2009.01.003_bib42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-0038-1647150","article-title":"Unbalanced coagulation-fibrinolysis potential during L-asparaginase therapy in children with acute lymphoblastic leukaemia","volume":"64","author":"Semeraro","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2009.01.003_bib43","first-page":"400","article-title":"Thrombosis in children receiving L-asparaginase. Determining patients at risk","volume":"15","author":"Shapiro","year":"1993","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.beha.2009.01.003_bib44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2008-1043788","article-title":"Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol","volume":"211","author":"Sutor","year":"1999","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.beha.2009.01.003_bib45","first-page":"108","article-title":"Children with acute lymphoblastic leukemia: is there any subgroup of children without elevated thrombin generation? A preliminary study utilizing measurements of thrombin-antithrombin III complexes","volume":"6","author":"Uszynski","year":"2000","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.beha.2009.01.003_bib46a","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/08880018609031197","article-title":"Correction of hemostatic imbalances induced by L-asparaginase therapy in children with acute lymphoblastic leukemia","volume":"3","author":"Zaunschirm","year":"1986","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.beha.2009.01.003_bib46b","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mpo.2950160304","article-title":"Increased antithrombin concentration in children with acute lymphoblastic leukemia receiving L-asparaginase therapy","volume":"16","author":"O'Meara","year":"1988","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.beha.2009.01.003_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0049-3848(01)00286-9","article-title":"Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase\/prednisone administration","volume":"103","author":"Nowak-G\u00f6ttl","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2009.01.003_bib48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/08880010500506701","article-title":"Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study","volume":"23","author":"Ruud","year":"2006","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.beha.2009.01.003_bib49","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s002470050649","article-title":"Pilot study of noninvasive detection of venous occlusions from central venous access devices in children treated for acute lymphoblastic leukemia","volume":"29","author":"Kaste","year":"1999","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.beha.2009.01.003_bib50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1538-7836.2008.02901.x","article-title":"Prevalence of post-thrombotic syndrome following asymptomatic thrombosis in survivors of acute lymphoblastic leukemia","volume":"6","author":"Kuhle","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.beha.2009.01.003_bib51","first-page":"119","article-title":"Clinical findings in the diagnosis of proximal deep vein thrombosis","volume":"75","author":"Molloy","year":"1982","journal-title":"Ir Med J"},{"key":"10.1016\/j.beha.2009.01.003_bib52","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1055\/s-0037-1613054","article-title":"Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase","volume":"87","author":"Male","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2009.01.003_bib53","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-2003-42588","article-title":"Diagnosis of venous thromboembolism in children","volume":"29","author":"Male","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.beha.2009.01.003_bib54","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1474-4422(07)70131-X","article-title":"Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study","volume":"6","author":"Kenet","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.beha.2009.01.003_bib55","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00043426-200306000-00011","article-title":"Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia","volume":"25","author":"Kieslich","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.beha.2009.01.003_bib56","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V83.2.386.386","article-title":"Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L-asparaginase-induced antithrombin III deficiency","volume":"83","author":"Mitchell","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.beha.2009.01.003_bib57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1160\/TH02-11-0283","article-title":"Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving L-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study","volume":"90","author":"Mitchell","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2009.01.003_bib58","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.mph.0000157379.44167.b5","article-title":"Ischemic stroke in children treated for acute lymphoblastic leukemia: a retrospective study","volume":"27","author":"Santoro","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.beha.2009.01.003_bib59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1067\/mpd.2001.111272","article-title":"Catheter-related thrombosis in children with cancer","volume":"138","author":"Glaser","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.beha.2009.01.003_bib60","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1200\/JCO.2005.12.097","article-title":"Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement","volume":"23","author":"McLean","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2009.01.003_bib61","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/CIRCULATIONAHA.108.789008","article-title":"Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies","volume":"118","author":"Young","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.beha.2009.01.003_bib62","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00001721-200107000-00005","article-title":"Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia","volume":"12","author":"Elhasid","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.beha.2009.01.003_bib63","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/blood-2002-06-1901","article-title":"Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration","volume":"101","author":"Nowak-G\u00f6ttl","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2009.01.003_bib64","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1365-2141.1997.d01-2046.x","article-title":"The factor V Leiden mutation in children with cancer and thrombosis","volume":"96","author":"Sifontes","year":"1997","journal-title":"Br J Haematol"},{"issue":"Suppl. 3","key":"10.1016\/j.beha.2009.01.003_bib65","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1007\/PL00014341","article-title":"Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters","volume":"158","author":"Wermes","year":"1999","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.beha.2009.01.003_bib66","first-page":"472","article-title":"Clotting abnormalities in children during maintenance chemotherapy for acute lymphoblastic leukemia","volume":"76","author":"Arico","year":"1991","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2009.01.003_bib67","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1182\/blood.V81.9.2468.bloodjournal8192468","article-title":"Hypercoagulability during induction therapy of acute lymphoblastic leukemia is of scarce clinical relevance. Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto","volume":"81","author":"de Stefano","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.beha.2009.01.003_bib68","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1200\/JCO.1987.5.5.811","article-title":"Effect of L-asparaginase administration on coagulation and platelet function in children with leukemia","volume":"5","author":"Homans","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2009.01.003_bib69","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/10428199909058436","article-title":"Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase","volume":"33","author":"Oner","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2009.01.003_bib70","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(80)91046-6","article-title":"Antithrombin III deficiency during asparaginase therapy","volume":"1","author":"Pitney","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2009.01.003_bib71","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/1097-0142(197710)40:4<1398::AID-CNCR2820400406>3.0.CO;2-#","article-title":"The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia","volume":"40","author":"Ramsay","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2009.01.003_bib72","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1182\/blood.V80.5.1366.1366","article-title":"Acute lymphoblastic leukemia: hypofibrinogenemia with a low incidence of clinical complications is often found during induction remission therapy","volume":"80","author":"Solano","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.beha.2009.01.003_bib73","series-title":"Cancer Medicine","first-page":"796","article-title":"L-asparaginase","author":"Capizzi","year":"1992"},{"key":"10.1016\/j.beha.2009.01.003_bib74","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1200\/JCO.1995.13.9.2474","article-title":"Loss of activity of Erwinia asparaginase on repeat applications","volume":"13","author":"Boos","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2009.01.003_bib75","first-page":"2297","article-title":"Biochemical and pharmacological studies with asparaginase in man","volume":"30","author":"Ohnuma","year":"1970","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2009.01.003_bib76","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0959-8049(96)00131-1","article-title":"Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations","volume":"32A","author":"Boos","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.beha.2009.01.003_bib77","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1182\/blood.V99.8.2734","article-title":"Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial","volume":"99","author":"Duval","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2009.01.003_bib78","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1538-7836.2007.02823.x","article-title":"Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: a meta-analysis","volume":"6","author":"Dentali","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.beha.2009.01.003_bib79","first-page":"1079","article-title":"T-immunophenotype is associated with an increased prevalence of thrombosis in children with acute lymphoblastic leukemia. A retrospective study","volume":"88","author":"Giordano","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2009.01.003_bib80","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/01.moh.0000160754.55131.14","article-title":"Long-term outcomes of venous thrombosis in children","volume":"12","author":"Goldenberg","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.beha.2009.01.003_bib81","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jpeds.2005.09.033","article-title":"Post-thrombotic syndrome is uncommon in childhood cancer survivors","volume":"148","author":"Journeycake","year":"2006","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beha.2009.01.003_bib82","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-0037-1613487","article-title":"PARKAA paves the way","volume":"90","author":"Korte","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2009.01.003_bib83","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1378\/chest.113.1.165","article-title":"Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials","volume":"113","author":"Randolph","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.beha.2009.01.003_bib84","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2004.07.019","article-title":"Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Group study","volume":"22","author":"Dillon","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2009.01.003_bib85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ajh.2830470302","article-title":"Fresh frozen plasma has no beneficial effect on the hemostatic system in children receiving L-asparaginase","volume":"47","author":"Halton","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2009.01.003_bib86","first-page":"451","article-title":"Inefficacy of fresh frozen plasma in the treatment of L-asparaginase-induced coagulation factor deficiencies during ALL induction therapy","volume":"80","author":"Nowak-G\u00f6ttl","year":"1995","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2009.01.003_bib87","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0609.1996.tb00290.x","article-title":"Inhibition of hypercoagulation by antithrombin substitution in E. coli L-asparaginase-treated children","volume":"56","author":"Nowak-G\u00f6ttl","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.beha.2009.01.003_bib88","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/08035250600729092","article-title":"Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies \u2013 a randomized, controlled study","volume":"95","author":"Ruud","year":"2006","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.beha.2009.01.003_bib89","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/pbc.21222","article-title":"Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia","volume":"50","author":"Meister","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl.","key":"10.1016\/j.beha.2009.01.003_bib90","doi-asserted-by":"crossref","first-page":"887S","DOI":"10.1378\/chest.08-0762","article-title":"Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Monagle","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.beha.2009.01.003_bib91","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1200\/JCO.1985.3.9.1266","article-title":"Altered von Willebrand factor molecule in children with thrombosis following asparaginase-prednisone-vincristine therapy for leukemia","volume":"3","author":"Pui","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2009.01.003_bib92","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2141.2005.05528.x","article-title":"Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease","volume":"129","author":"Athale","year":"2005","journal-title":"Br J Haematol"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692609000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692609000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T18:34:42Z","timestamp":1589654082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692609000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1521692609000048"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2009.01.003","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}